Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
Clinical trial NCT03688711 · COMPLETED
Trial details
- NCT number
- NCT03688711
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2019-03-11
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.